IDiyas

For the Inventor, By the Inventor

Morris Plains, NJ, United States of America

Thomas K Morgan, Jr

USPTO Granted Patents = 12

Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 60(Granted Patents)


Company Filing History:

goldMedal10 out of 1,384 
 
Schering Aktiengesellschaft
 patents
silverMedal2 out of 100 
 
Berlex Laboratories, Inc.
 patents

Years Active: 1982-1993

Loading Chart...
12 patents (USPTO):Explore Patents
1. 5189036 - Imidazolylbenzoyl substituted heterocycles (1993-02-23),
2. 5051423 - Derivatized alkanolamines as cardiovascular agents (1991-09-24),
3. 5051422 - 2-substituted-1(4)-aryl piperazines and the process for their preparation (1991-09-24),
4. 4920116 - N-(aminoalkyl)-substituted(N or C (1990-04-24),
5. 4900841 - 1-[4-[(methyl-sulfonyl)amino]benzoyl]aziridine (1990-02-13),
6. 4804662 - Substituted 4-(1H-imidazol-1-yl)benzamides as antiarrhythmic agents (1989-02-14),
7. 4689341 - Antiarrhythmic imidazoles (1987-08-25),
8. 4613609 - Antiarrhythmic imidazoliums (1986-09-23),
9. 4599344 - Quinuclidines and quinuclidinium salts as antiarrhythmic agents (1986-07-08),
10. 4581370 - Antiarrhythmic imidazoliums (1986-04-08),
11. 4415587 - Method of use of antiarrhythmic 1-arylcarbamoylalkyl imidazole (1983-11-15),
12. 4353921 - Antiarrythmic 1-arylcarbamoylalkyl-2-imidazoline derivatives, (1982-10-12),

Title: Thomas K Morgan, Jr: Innovator in Cardiovascular Pharmaceuticals

Introduction

Thomas K Morgan, Jr. is a notable inventor based in Morris Plains, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of cardiovascular agents. With a total of 12 patents to his name, Morgan's work has had a profound impact on medical science.

Latest Patents

Among his latest patents, Morgan has developed novel imidazolylbenzoyl substituted heterocycles. These compounds are described for their use as cardiovascular agents, especially as Class III antiarrhythmic agents. Additionally, he has worked on pharmaceutical formulations containing such compounds. Another significant invention is related to 2-substituted-1(4)-aryl piperazines and the process for their preparation. These compounds have been found to exhibit cardiovascular effects, primarily antiarrhythmic, and are characterized by a specific general formula.

Career Highlights

Throughout his career, Thomas K Morgan, Jr. has worked with prominent companies in the pharmaceutical industry, including Schering Aktiengesellschaft and Berlex Laboratories, Inc. His expertise in cardiovascular pharmaceuticals has positioned him as a key figure in the development of innovative treatments.

Collaborations

Morgan has collaborated with notable individuals in his field, including Ronald A Wohl and William C Lumma, Jr. These collaborations have contributed to the advancement of his research and inventions.

Conclusion

Thomas K Morgan, Jr. is a distinguished inventor whose work in cardiovascular pharmaceuticals has led to significant advancements in medical treatments. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…